|
Pharmaceutical Products – Conclusion Of Discount Agreements In Accordance With Section 130A Paragraph 8 Sgb V For Pharmaceuticals In The Generic Market. Atorvastatin,Candesartan,Candesartan+Hydrochlorothiazid,Cinacalcet (Film-Coated Tablets Only),Clozapine,Dexamethasone (Without Implants),Enalapril+Lercanidipin,Enoxaparin Natrium,Eslicarbazepin,Etoricoxib,Olanzapine (Solid Oral Dosage Forms Only),Olmesartan+Amlodipin+Hydrochlorothiazid,Quetiapin,Rizatriptan,Salmeterol+Fluticason,Valsartan+Amlodipine,Valsartan+Hydrochlorothiazid,Ziprasidone (Hard Capsules Only),Zoledronic Acid,Axitinib,Brinzolamid,Budesonide (Rhinologics And Inhalants Only),Capecitabin,Clopidogrel,Dimethyl Fumarate (Enteric-Coated Hard Capsules Only),Duloxetine Bik (Minimum Indication Stress Urinary Incontinence),Duloxetine Gas (Minimum Indication Generalized Anxiety Disorder),Exemestan,Imatinib,Lamivudine,Latanoprost,Letrozole (Sex Hormones And Inhibitors Only),Levonorgestrel+Ethinylestradiol,Oxycodone+Naloxone,Progesterone (Soft Capsules Only),Ranolazine,Rivaroxaban (Only Film-Coated Tablets With The Active Ingredient Strengths 10Mg, 15Mg And 20Mg),Rosuvastatin+Ezetimib,Sapropterin,Tapentadol (Extended-Release Tablets Only),Tenofovir Disoproxil (Only Film-Coated Tablets With A Potency Of 245 Mg),Teriflunomid,Ticagrelor,Tilidin Hydrochlorid+Naloxon Hydrochlorid,Travoprost+Timolol,Valganciclovir (Film-Coated Tablets Only)
|
